Efficacy and Safety of Sugammadex versus Neostigmine in Reversing Neuromuscular Blockade in Morbidly Obese Adult Patients | Zendy

Yamini Subramani | Zendy; Jill Querney | Zendy; Susan He | Zendy; Mahesh Nagappa | Zendy; H. Keri Yang | Zendy; Ashraf Fayad | Zendy

Open Access

Efficacy and Safety of Sugammadex versus Neostigmine in Reversing Neuromuscular Blockade in Morbidly Obese Adult Patients

Author(s) -

Yamini Subramani,

Jill Querney,

Susan He,

Mahesh Nagappa,

H. Keri Yang,

Ashraf Fayad

Publication year - 2021

Publication title -

anesthesia essays and researches

Language(s) - English

Resource type - Journals

ISSN - 0259-1162

DOI - 10.4103/aer.aer_79_21

Subject(s) - sugammadex , neostigmine , medicine , anesthesia , confidence interval , neuromuscular blockade , adverse effect , odds ratio , meta analysis , rocuronium , intubation

Sugammadex is known to reverse neuromuscular blockade (NMB) more rapidly and reliably than neostigmine. However, data remain limited in bariatric patients. In this review, we systematically evaluated the efficacy and safety of sugammadex versus neostigmine in reversing NMB in morbidly obese (MO) patients undergoing bariatric surgery.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research